Cargando…
Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158807/ https://www.ncbi.nlm.nih.gov/pubmed/32376072 http://dx.doi.org/10.1016/j.rgmx.2020.04.001 |
_version_ | 1783522559378063360 |
---|---|
author | Schmulson, M. Dávalos, M.F. Berumen, J. |
author_facet | Schmulson, M. Dávalos, M.F. Berumen, J. |
author_sort | Schmulson, M. |
collection | PubMed |
description | BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varied from 3.0% to 39.6% and included diarrhea (7.5%), náusea (4.5%), anorexia (4.4%), vomiting (1.3%), abdominal pain (0.5%), and belching/reflux (0.3%). Those symptoms can be the first manifestation of COVID-19, but whether they reflect a better or worse prognosis, is controversial. The potential relation of the angiotensin converting enzyme 2 receptor in the digestive tract as an entry route for the virus is discussed. CONCLUSION: Gastrointestinal symptoms may be common in COVID-19, in some cases appearing as the first manifestation, even before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists must be aware of those atypical cases during the current pandemic, as well as of the fecal-oral route and corresponding preventive measures. |
format | Online Article Text |
id | pubmed-7158807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71588072020-04-15 Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 Schmulson, M. Dávalos, M.F. Berumen, J. Rev Gastroenterol Mex Article BACKGROUND: There is an increasing number of reports on the presentation of gastrointestinal symptoms in cases of COVID-19. AIM: To review the studies reporting gastrointestinal symptoms in COVID-19. RESULTS: Fifteen articles (2,800 patients) were identified. Gastrointestinal symptom frequency varied from 3.0% to 39.6% and included diarrhea (7.5%), náusea (4.5%), anorexia (4.4%), vomiting (1.3%), abdominal pain (0.5%), and belching/reflux (0.3%). Those symptoms can be the first manifestation of COVID-19, but whether they reflect a better or worse prognosis, is controversial. The potential relation of the angiotensin converting enzyme 2 receptor in the digestive tract as an entry route for the virus is discussed. CONCLUSION: Gastrointestinal symptoms may be common in COVID-19, in some cases appearing as the first manifestation, even before fever and respiratory symptoms. Therefore, clinicians and gastroenterologists must be aware of those atypical cases during the current pandemic, as well as of the fecal-oral route and corresponding preventive measures. Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. 2020 2020-04-15 /pmc/articles/PMC7158807/ /pubmed/32376072 http://dx.doi.org/10.1016/j.rgmx.2020.04.001 Text en © 2020 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Schmulson, M. Dávalos, M.F. Berumen, J. Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 |
title | Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 |
title_full | Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 |
title_fullStr | Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 |
title_full_unstemmed | Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 |
title_short | Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19 |
title_sort | alerta: los síntomas gastrointestinales podrían ser una manifestación de la covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158807/ https://www.ncbi.nlm.nih.gov/pubmed/32376072 http://dx.doi.org/10.1016/j.rgmx.2020.04.001 |
work_keys_str_mv | AT schmulsonm alertalossintomasgastrointestinalespodrianserunamanifestaciondelacovid19 AT davalosmf alertalossintomasgastrointestinalespodrianserunamanifestaciondelacovid19 AT berumenj alertalossintomasgastrointestinalespodrianserunamanifestaciondelacovid19 |